Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;72(4):374-80.
doi: 10.4046/trd.2012.72.4.374. Epub 2012 Apr 30.

The Current Status of BCG Vaccination in Young Children in South Korea

Affiliations

The Current Status of BCG Vaccination in Young Children in South Korea

Hyejon Lee et al. Tuberc Respir Dis (Seoul). 2012 Apr.

Abstract

Background: Delivery of Bacille Calmette-Guréin (BCG) Tokyo vaccine, with the multipuncture device, has been much preferred over BCG Pasteur, with the intradermal method, possibly due to the easier manner of administration, a desire to avoid any trouble with scars, as well as side effects and higher profits to providers in South Korea.

Methods: To determine BCG scar status in 0~6 year old children vaccinated with two BCG vaccines (Pasteur BCG vaccine with intradermal method and BCG Tokyo vaccine with percutaneous method), the data from the national BCG scar survey in 2006 was analyzed.

Results: Based on the national survey, the high proportion that were vaccinated with BCG Tokyo vaccines with the multipuncture method (64.5%) was noted in 0~6 year old Korean children. From inspection of scar formation, as an indicator of vaccination, the median number of the visible pin scars from the percutaneous method was 16 (interquartile range, 12~18) in the Korean children, and pin scars decreased as the age of the children increased (p<0.001).

Conclusion: The findings in this survey clearly showed a growing preference of parents for the BCG Tokyo vaccines by the multipuncture method in South Korea.

Keywords: BCG Vaccine; Tuberculosis; Vaccination.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of scar size (mm) among BCG Pasteur recipients by age. The figure excludes data from children with no scar. The different lines indicate each age group from 0 year to 6 years old. BCG: Bacille Calmette-Guréin.

Similar articles

Cited by

References

    1. Tan JS, Canaday DH, Boom WH, Balaji KN, Schwander SK, Rich EA. Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J Immunol. 1997;159:290–297. - PubMed
    1. Kim HJ, Oh SY, Lee JB, Park YS, Lew WJ. Tuberculin survey to estimate the prevalence of tuberculosis infection of the elementary schoolchildren under high BCG vaccination coverage. Tuberc Respir Dis. 2008;65:269–276.
    1. Kim HJ, Oh SY, Lee JB. Report on Comparison of Each Strain (Pasteur, Danish, Tokyo) of BCG Efficacy Using Tuberculin Test and Adverse Reactions. Seoul: Korean Institute of Tuberculosis; 2008.
    1. Fine PE, Carneiro IA, Milstien JB, Clements CJ. Issues relating to the use of BCG immunization programmes. Report No. WHO/V&B/99.23. Geneva: World Health Organization; 1999.
    1. Gheorghiu M. The present and future role of BCG vaccine in tuberculosis control. Biologicals. 1990;18:135–141. - PubMed